Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.

UNLABELLED This study examined the gene transfer efficiency and toxicity of 2-kDa polyethylenimine conjugated to gold nanoparticles (PEI2-GNPs) in the human cornea in vitro and rabbit cornea in vivo. PEI2-GNPs with nitrogen-to-phosphorus ratios of up to 180 exhibited significant transgene delivery in the human cornea without altering the viability or phenotype of these cells. Similarly, PEI2-GNPs applied to corneal tissues collected after 12 hours, 72 hours, or 7 days exhibited appreciable gold uptake throughout the rabbit stroma with gradual clearance of GNPs over time. Transmission electron microscopy detected GNPs in the keratocytes and the extracellular matrix of the rabbit corneas. Additionally, slit-lamp biomicroscopy in live animals even 7 days after topical PEI2-GNP application to the cornea detected no inflammation, redness, or edema in rabbit eyes in vivo, with only moderate cell death and immune reactions. These results suggest that PEI2-GNPs are safe for the cornea and can potentially be useful for corneal gene therapy in vivo. FROM THE CLINICAL EDITOR This study examined the gene transfer efficiency and toxicity of 2-kDa polyethylenimine conjugated to gold nanoparticles in the human cornea in vitro and rabbit cornea in vivo. The results suggest that PEI2-GNPs are safe for the cornea and can potentially be useful for corneal gene therapy in vivo.

[1]  Chad A Mirkin,et al.  Gold nanoparticles for biology and medicine. , 2010, Angewandte Chemie.

[2]  F. Szoka,et al.  Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.

[3]  Jin Wang,et al.  The effect of nocodazole on the transfection efficiency of lipid-bilayer coated gold nanoparticles. , 2009, Biomaterials.

[4]  Shannon M. Conley,et al.  Nanoparticle applications in ocular gene therapy , 2008, Vision Research.

[5]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.

[6]  Chad A. Mirkin,et al.  Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation , 2006, Science.

[7]  Vincent M Rotello,et al.  Gold nanoparticle-mediated transfection of mammalian cells. , 2002, Bioconjugate chemistry.

[8]  Vincent M Rotello,et al.  Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. , 2008, ACS nano.

[9]  S Moein Moghimi,et al.  A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[11]  B. Liu,et al.  The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. , 2008, Biomaterials.

[12]  R. Mohan,et al.  Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. , 2003, Experimental eye research.

[13]  A. Ljubimov,et al.  Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met gene. , 2010, Investigative ophthalmology & visual science.

[14]  J. Feijen,et al.  Reducible poly(amido ethylenimine) directed to enhance RNA interference. , 2007, Biomaterials.

[15]  T. Sugaya,et al.  In vivo gene delivery by cationic tetraamino fullerene , 2010, Proceedings of the National Academy of Sciences.

[16]  Joseph C. Besharse,et al.  Encyclopedia of the eye , 2010 .

[17]  M. Tai,et al.  Dehydrated Form of Plasmid Expressing Basic Fibroblast Growth Factor–Polyethylenimine Complex Is a Novel and Accurate Method for Gene Transfer to the Cornea , 2005, Current eye research.

[18]  U. Pleyer,et al.  Lipid-mediated gene transfer of acidic fibroblast growth factor into human corneal endothelial cells. , 2005, Experimental eye research.

[19]  B. Ambati,et al.  Corneal transparency: Genesis, maintenance and dysfunction , 2010, Brain Research Bulletin.

[20]  Robert K Prud'homme,et al.  Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy , 2009, Expert opinion on drug delivery.

[21]  J F Hainfeld,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.

[22]  H. Volk,et al.  Effects of interleukin-12p40 gene transfer on rat corneal allograft survival. , 2007, Transplant immunology.

[23]  R. Mohan,et al.  Gene therapy in the cornea , 2005, Progress in Retinal and Eye Research.

[24]  Amy C Richards Grayson,et al.  Biophysical and Structural Characterization of Polyethylenimine-Mediated siRNA Delivery in Vitro , 2006, Pharmaceutical Research.

[25]  Matthias Epple,et al.  Inorganic nanoparticles as carriers of nucleic acids into cells. , 2008, Angewandte Chemie.

[26]  B. Hinz,et al.  Efficiency and toxicity of liposome-mediated gene transfer to corneal endothelial cells. , 2001, Experimental eye research.

[27]  R. Mohan,et al.  Trichostatin a inhibits corneal haze in vitro and in vivo. , 2009, Investigative ophthalmology & visual science.

[28]  W. Hauswirth,et al.  Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy , 2008, Molecular vision.

[29]  Dakrong Pissuwan,et al.  The forthcoming applications of gold nanoparticles in drug and gene delivery systems. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[30]  A. Ragusa,et al.  Nanoparticles as Nonviral Gene Delivery Vectors , 2007, IEEE Transactions on NanoBioscience.

[31]  R. Lockey,et al.  Nanoparticle-mediated gene delivery: state of the art , 2004, Expert opinion on biological therapy.

[32]  R. Mohan,et al.  Transduction efficiency of AAV 2/6, 2/8 and 2/9 vectors for delivering genes in human corneal fibroblasts , 2010, Brain Research Bulletin.

[33]  Jianzhu Chen,et al.  Cross-linked Small Polyethylenimines: While Still Nontoxic, Deliver DNA Efficiently to Mammalian Cells in Vitro and in Vivo , 2005, Pharmaceutical Research.

[34]  E. Stachowiak,et al.  Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Sha Jin,et al.  Nanoparticle-mediated gene delivery. , 2009, Methods in molecular biology.

[36]  Toshihiro Akaike,et al.  Bio-functional inorganic materials: an attractive branch of gene-based nano-medicine delivery for 21st century. , 2005, Current gene therapy.

[37]  Weihong Tan,et al.  Nanoparticles for multiplex diagnostics and imaging. , 2006, Nanomedicine.

[38]  C. Andrieu-Soler,et al.  Ocular gene therapy: a review of nonviral strategies. , 2006, Molecular vision.

[39]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[40]  J. Tovey,et al.  AAV serotype influences gene transfer in corneal stroma in vivo. , 2010, Experimental eye research.

[41]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[42]  Alexander M. Klibanov,et al.  Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.